Insiders · Profile

Olinger Margaret

Chief Commercial Officer at Amylyx Pharmaceuticals. Filing since 6 Jan 2022. CIK 0001898725

Company
Date
Role
Action
Shares
Amount
Of holding
6 Jan 2023
Chief Commercial Officer
Bought
2,403
$87.23K
1.1%
6 Jan 2022
Chief Commercial Officer
Bought
6,842
$130.00K
3.3%
2 decisions on file.